Publications 2020

1. HANDALA L, BLANCHARD E, RAYNAL, PI, ROINGEARD P, MOREL V, DESCAMPS V, CASTELAIN S, FRANÇOIS C, DUVERLIE G, BROCHOT E, HELLE F. BK polyomavirus hijacks extracellular vesicles for en bloc transmission. J Virol 2020 ; 94: e01834-19

2. ROINGEARD P, BEAUMONT E. Hepatitis C vaccine : 10 good reasons for continuing. Hepatology 2020 ; 71: 1845-1850.

3. PILLONEL J, PELAT C, TIBERGHIEN P, SAUVAGE C, DANIC B, MARTINAUD C, BARIN F, SAINTE-MARIE I, COIGNARD B, GROSS S, LAPERCHE S, LOT F. The evolving blood donor deferral policy for men who have sex with men: impact on the risk of HIV transmission by transfusion in France. Transfusion 2020 ; 60:525-534.

4. BASSET J, BURLAUD-GAILLARD J, FEHER M, ROINGEARD P, REY F, PARDIGON N. A molecular determinant of West Nile virus secretion and 1 morphology as a target for viral attenuation. J Virol 2020 ; 94: e00086-20.

5. HERRSCHER C, PASTOR F, BURLAUD-GAILLARD J, DUMANS A, SEIGNEURET F, MOREAU A, EYMIEUX S, HOURIOUX C, ROINGEARD P, BLANCHARD E. Hepatitis B virus entry into HepG2-NTCP cells depends on clathrin-mediated endocytosis. Cell Microbiol 2020, e13205.

6. RAT V, PINSON X, SEIGNEURET F, DURAND S, HERRSCHER C, LEMOINE R, BURLAUD-GAILLARD J, RAYNAL PI, HOURIOUX C, ROINGEARD P, TRAMIER M, DE ROCQUIGNY H. Hepatitis B virus core protein domains essential for viral capsid assembly in a cellular context. J Mol Biol 2020 ; 432, 3802–3819.

7. HERRSCHER C, ROINGEARD P, BLANCHARD E. Hepatitis B virus entry into cells. Cells 2020 ; 9: e1486.

8. STEFIC K, MAHJOUB N, DESOUCHE C, NÉRÉ ML, THIERRY D, DELAUGERRE C, BARIN F, CHAIX ML. Difficulties of Identifying the Early HIV Antibody Seroconversion Period Depending on the Confirmatory Assay. Open Forum Infect Dis 2020 ; 7:ofaa140.

9. TROUILLER P, VELTER A, SABONI L, SOMMEN C, SAUVAGE C, VAUX S, BARIN F, CHEVALIEZ S, LOT F, JAUFFRET-ROUSTIDE M and the Prevagay group. Injecting drug use during sex (known as "slamming") among men who have sex with men: Results from a time-location sampling survey conducted in five cities, France. Int J Drug Policy 2020 ; 79:102703.

10. CHAZAL N, DE ROCQUIGNY H, ROUSSEL P, BOUAZIZ S, BARRE-SINOUSSI F, DELFRAISSY JF, DARLIX JL. The three lives of Pierre Boulanger. Retrovirology 2020 ; 17: 9.

11. BOSSEBOEUF A, MENNESSON N, ALLAIN-MAILLET S, TALLET A, PIVER E, DECAUX O, MOREAU C, MOREAU P, LEHOURS P, MÉGRAUD F, SALLE V, BIGOT-CORBEL E, HARB J, HERMOUET S. Characteristics of MGUS and Multiple Myeloma According to the Target of Monoclonal Immunoglobulins, Glucosylsphingosine, or Epstein-Barr Virus EBNA-1. Cancers 2020 ;12:1254.

12. AIDOUD A, MARLET J, ANGOULVANT D, DEBACQ C, GAVAZZI G, FOUGÈRE B. Influenza vaccination as a novel means of preventing coronary heart disease: Effectiveness in older adults. Vaccine 2020 ; 38:4944-4955.

13. GONZALES B, DE ROCQUIGNY H, BEZIAU A, DURAND S, BURLAUD-GAILLARD J, LEFEBVRE, KRULL S, EMOND P, BRAND D, PIVER E. Type I phosphatidylinositol-4-phosphate 5-kinase alpha and gamma play a key role in targeting HIV-1 PR55Gag to the plasma membrane. J Virol 2020 ; 94 :189-20.

14. BEAUMONT E, CLÉMENT BJ, GUÉRIN V, CHOPIN L, ROCH E, GOMEZ-ESCOBAR E, ROINGEARD P. Mixing particles from various HCV genotypes increases the HBV-HCV vaccine ability to elicit broadly cross-neutralizing antibodies. Liver International 2020 ; 40:1865-1871.

15. DE ROCQUIGNY H, RAT V, PASTOR F, DARLIX JL, HOURIOUX C, ROINGEARD P. Phosphorylation of the arginine rich C-terminal domain of the hepatitis B virus (HBV) core protein as a fine regulator of the HBV life cycle. Viruses 2020 ; 12:738.

16. LEGROS V, JEANNIN P, BURLAUD-GAILLARD J, CHAZE T, GIAIA GIANETTO Q, BUTLER-BROWNE G, MOULY V, ZOLADEK J, AFONSO P, GONZALEZ M-N, MATONDO M, RIEDETER I, ROINGEARD P, GESSAIN A, CHOUMET V, CECCALDI P-E. Differentiation-dependent susceptibility of human muscle cells to Zika virus infection. PloS Negl Trop Dis 2020, 14(8): e0008282.

17. AMBLARD F, BOUCLE S, BASSIT L, COX B, SARI O, TAO S, CHEN Z, OZTURK T, VERMA K, RUSSELL O, RAT V, DE ROCQUIGNY H, FIQUET O, BOUSSAND M, DI SANTO J, STRICK-MARCHAND H, SCHINAZI RF. Novel Hepatitis B Virus Capsid Assembly Modulator Induces Potent Antiviral Responses in Vitro and in Humanized Mice. Antimicrob Agents Chemother 2020 ; pii e01701-19.

18. BAILLY E, STEFIC K, GATAULT P, MIQUELESTORENA-STANDLEY E, MACHET MC, BARBET C, BARIN F, HALIMI JM. Prevention of parvovirus B19-induced repetitive acute kidney failure by subcutaneous immunoglobulins. Fundam Clin Pharmacol 2020 ; 34: 296-298

19. BOUTANT E, BONZI J, ANTON H, BIN NASIM M, CATHAGNE R, RÉAL E, DUJARDIN D, CARL P, DIDIER P, PAILLART J, MARQUET R, MÉLY Y, DE ROCQUIGNY* H, BERNACCHI* S. The two zinc fingers in the nucleocapsid domain of the HIV-1 Gag precursor are equivalent for the interaction with the genomic RNA in the cytoplasm, but not for the recruitment of the complexes at the plasma membrane. Biophys J 2020 ; 119:419-433.

20. MARLET J, LIER C, ROCH A, MAUGEY M, MOREAU A, COMBE B, LEFEUVRE S, D’ALTEROCHE L, BARBEREAU D, CAUSSE X, BASTIDES F, BACHELIER M-N, BRAND D, GAUDY-GRAFFIN C. Revisiting HBV resistance to entecavir with a phenotypic approach. Antiviral Research 2020 ; 181:104869.

21. KARNIB H, NADEEM MF, HUMBERT N, SHARMA KK, GRYTSYK N, TISNÉ C, BOUTANT E, LEQUEU T, RÉAL E, BOUDIER C, DE ROCQUIGNY H* & MÉLY Y*. (2020). The nucleic acid chaperone activity of the HIV-1 Gag polyprotein is boosted by its cellular partner RPL7: a kinetic study. Nucleic Acids Res 2020 ; 48:9218-9234.

22. BERNARD L, DESOUBEAUX G, BODIER-MONTAGUTELLI, PARDESSUS J, BREA D, ALLIMONNIER L, EYMIEUX S, RAYNAL P-I, VASSEUR V, VECELLIO L, MATHE L, GUILLON A, LANOTTE P, POURCHEZ J, VERHOEVEN P, ESNOUF S, FERRY M, ETERRADOSSI N, BLANCHARD Y, BROWN P, ROINGEARD P, ALCATRAZ JP, CINQUIN P, SI-TAHAR M, HEUZE-VOURC’H N. Controlled heat and humidity-based treatment for the re-use of personal protective equipement: a pragmatic proof-of-concept to address the mass shortage of surgical masks and N95/FFP2 respirators, and to prevent SARS-CoV2 transmission. Front Med (Lausanne) 2020 ; 7 : 584036.


24. BOUVIN-PLEY M, LEOZ M, ROCH E, MOREAU M, MIGRAINE M, BELLINI N, BLAKE O, MAMMANO F, BRAIBANT M, PLANTIER J-C, BRAND D. Differential utilization of CD4 by transmitted/founder and chronic envelope glycoproteins in a MSM HIV-1 subtype B transmission cluster AIDS 2020 ; 34: 2187-2200.

25. MARLET J, PETILLON C, RAGOT E, ABOU EL FATTAH Y, GUILLON A, MARCHAND ADAM S, LEMAIGNEN A, BERNARD L, DESOUBEAUX G, BLASCO H, BARIN F, STEFIC K, GAUDY-GRAFFIN C. Clinical performance of four immunoassays for antibodies to SARS-CoV-2, including a prospective analysis for the diagnosis of COVID-19 in a real-life routine care setting. J Clin Virol 2020 ; 132:104633.

26. BERETTA M, MIGRAINE J, MOREAU A, ESSAT A, GOUJARD C, CHAIX M-L, DROUIN A, BOUVIN-PLEY M, MEYER L, BARIN F, BRAIBANT M. Common evolutionary features of the envelope glycoprotein of HIV-1 in patients belonging to a transmission chain. Sci Rep 2020 ; 10 : 16824.

27. BEZIAU A, BRAND D, PIVER E. The Role of Phosphatidylinositol Phosphate Kinases During Viral Infection. Viruses 2020 ; 12:1124.

28. HUBERT M, JEANNIN P, BURLAUD-GAILLARD J, ROINGEARD P, GESSAIN A, CECCALDI PE, VIDY A. Evidence that Zika virus is transmitted by breastfeeding to newborn A129 (Ifnar1 Knock-out) mice and is able to infect and cross a thight monolayer of human intestinal epithelial cells. Front Microbiol 2020 ; 11: 524678.

29. BLASCO H, BESSY C, PLANTIER L, LEFEVRE A, PIVER E, BERNARD L, MARLET J, STEFIC K, BENZ-DE BRETAGNE I, CANNET P, LUMBU H, MOREL T, BOULARD P, ANDRES CR, VOURC'H P, HÉRAULT O, GUILLON A, EMOND P. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism. Sci Rep 2020 ; 10:16824.